March 22, 2019
UBS Analyst Atsushi Seki Too many pharmaceutical manufacturers are flocking to oncology drug development, causing overcompetition in the market, which makes it hard for companies to recoup investments, UBS analyst Atsushi Seki says. “Haven’t we had enough of oncology players?...read more